GB2014043A - Injectable embolization and occlusion solutions - Google Patents

Injectable embolization and occlusion solutions

Info

Publication number
GB2014043A
GB2014043A GB7903005A GB7903005A GB2014043A GB 2014043 A GB2014043 A GB 2014043A GB 7903005 A GB7903005 A GB 7903005A GB 7903005 A GB7903005 A GB 7903005A GB 2014043 A GB2014043 A GB 2014043A
Authority
GB
United Kingdom
Prior art keywords
solutions
sodium
occlusion
injectable
embolization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB7903005A
Other versions
GB2014043B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethicon Inc
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Publication of GB2014043A publication Critical patent/GB2014043A/en
Application granted granted Critical
Publication of GB2014043B publication Critical patent/GB2014043B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452—Solutions, e.g. for injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

An injectable solution containing a prolamine e.g. zein, gliadin and hordein is provided for the closure of organs, their duct systems or blood vessels in animals and humans. The solutions may also contain specific pancreas inhibitors, antimicrobials, cytostatics, radioactives and X-ray contrast media e.g. sodium amidotrizoate, sodium acetriozate, sodium 2-iodohipparate and amidotrizoic acid.
GB7903005A 1978-01-30 1979-01-29 Injectable embolization and occlusion solution Expired GB2014043B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2803869A DE2803869C2 (en) 1978-01-30 1978-01-30 Injectable embolization and occlusion solution

Publications (2)

Publication Number Publication Date
GB2014043A true GB2014043A (en) 1979-08-22
GB2014043B GB2014043B (en) 1982-08-11

Family

ID=6030689

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7903005A Expired GB2014043B (en) 1978-01-30 1979-01-29 Injectable embolization and occlusion solution

Country Status (8)

Country Link
JP (1) JPS54123281A (en)
AT (1) AT363599B (en)
AU (1) AU525929B2 (en)
CA (1) CA1116088A (en)
DE (1) DE2803869C2 (en)
FR (1) FR2415464A1 (en)
GB (1) GB2014043B (en)
NL (1) NL191433C (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0115549A1 (en) * 1983-02-03 1984-08-15 Ethicon, Inc. Paste for hemostasis and for temporary relief of defects in the traumatism of bones
EP0128578A1 (en) * 1983-06-14 1984-12-19 Byk Gulden Lomberg Chemische Fabrik GmbH Ethanolic suspensions of contrast agents
FR2548022A1 (en) * 1983-06-30 1985-01-04 Ispytatelny Inst Med COMPOSITION FOR EMBOLIZATION OF BLOOD VESSELS CONTAINING POLYMERIC MATERIAL AS EMBOLIZING MATERIAL
EP0194644A2 (en) * 1985-03-15 1986-09-17 See/Shell Biotechnology, Inc. Biodegradable microspheres and method for their preparation
WO1997036576A1 (en) * 1996-04-01 1997-10-09 Korea Institute Of Science And Technology Preparation method of emulsion for chemoembolization
EP1191947A1 (en) * 1999-05-13 2002-04-03 Micro Therapeutics, Inc. Methods for treating avm' using radioactive compositions
WO2004058310A1 (en) * 2002-12-30 2004-07-15 Friedhelm Brassel Liquid embolisate
WO2008034270A3 (en) * 2006-09-18 2008-11-13 Forim X Ag X-ray contrast agent for post-mortem experimental and diagnostic angiography
CH712511B1 (en) * 2006-09-18 2017-11-30 Forim-X Ag C/O Prof Dr Med Richard Dirnhofer X-ray contrast media for postmortem, experimental and diagnostic angiography.
CN113813392A (en) * 2021-10-23 2021-12-21 哈尔滨工业大学 Preparation method of blood cell-like drug carrier

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19608278A1 (en) * 1996-02-23 1997-08-28 Schering Ag Pharmaceutical compositions containing perfluoroalkyl-containing metal complexes, and their use in tumor therapy and interventional radiology
US6180113B1 (en) 1996-02-23 2001-01-30 Schering Ag Pharmaceutical agents that contain perfluoroalkyl-containing metal complexes
CN107935870A (en) * 2017-11-09 2018-04-20 华中药业股份有限公司 A kind of synthetic method of 2 methylamino, 5 chlorobenzophenone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB311382A (en) * 1928-05-10 1930-08-07 H A Metz Lab Inc Improvements in or relating to the manufacture of spinal anaesthetic solutions
CA958642A (en) * 1969-06-11 1974-12-03 Milos Sovak Contrast media for radiography

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0115549A1 (en) * 1983-02-03 1984-08-15 Ethicon, Inc. Paste for hemostasis and for temporary relief of defects in the traumatism of bones
EP0128578A1 (en) * 1983-06-14 1984-12-19 Byk Gulden Lomberg Chemische Fabrik GmbH Ethanolic suspensions of contrast agents
FR2548022A1 (en) * 1983-06-30 1985-01-04 Ispytatelny Inst Med COMPOSITION FOR EMBOLIZATION OF BLOOD VESSELS CONTAINING POLYMERIC MATERIAL AS EMBOLIZING MATERIAL
GB2144327A (en) * 1983-06-30 1985-03-06 Vnii Ispytatel Med Tech Composition for the embolization of blood vessels/radiopaques
US4999188A (en) * 1983-06-30 1991-03-12 Solodovnik Valentin D Methods for embolization of blood vessels
EP0194644A2 (en) * 1985-03-15 1986-09-17 See/Shell Biotechnology, Inc. Biodegradable microspheres and method for their preparation
EP0194644A3 (en) * 1985-03-15 1987-09-30 William Elson Shell Biodegradable microspheres and method for their preparation
WO1997036576A1 (en) * 1996-04-01 1997-10-09 Korea Institute Of Science And Technology Preparation method of emulsion for chemoembolization
EP1191947A1 (en) * 1999-05-13 2002-04-03 Micro Therapeutics, Inc. Methods for treating avm' using radioactive compositions
EP1191947A4 (en) * 1999-05-13 2003-07-16 Micro Therapeutics Inc Methods for treating avm' using radioactive compositions
US6759028B2 (en) 1999-05-13 2004-07-06 Micro Therapeutics, Inc. Methods for treating AVM's using radioactive compositions
WO2004058310A1 (en) * 2002-12-30 2004-07-15 Friedhelm Brassel Liquid embolisate
WO2008034270A3 (en) * 2006-09-18 2008-11-13 Forim X Ag X-ray contrast agent for post-mortem experimental and diagnostic angiography
EP2526973A3 (en) * 2006-09-18 2013-01-16 Forim-X AG X ray contrasting agent for post-mortem, experimental and diagnostic angiography
US8367041B2 (en) 2006-09-18 2013-02-05 Forim-X Ag Radiographic contrast agent for postmortem, experimental and diagnostic angiography
US8992888B2 (en) 2006-09-18 2015-03-31 Forim-X Ag Radiographic contrast agent for postmortem, experimental and diagnostic angiography
CH712511B1 (en) * 2006-09-18 2017-11-30 Forim-X Ag C/O Prof Dr Med Richard Dirnhofer X-ray contrast media for postmortem, experimental and diagnostic angiography.
CN113813392A (en) * 2021-10-23 2021-12-21 哈尔滨工业大学 Preparation method of blood cell-like drug carrier

Also Published As

Publication number Publication date
NL191433C (en) 1995-07-04
AU4343079A (en) 1979-08-09
AT363599B (en) 1981-08-10
JPS54123281A (en) 1979-09-25
DE2803869C2 (en) 1983-12-29
GB2014043B (en) 1982-08-11
JPH0129774B2 (en) 1989-06-14
NL7900649A (en) 1979-08-01
FR2415464A1 (en) 1979-08-24
DE2803869A1 (en) 1979-08-02
CA1116088A (en) 1982-01-12
FR2415464B1 (en) 1983-07-01
NL191433B (en) 1995-03-01
AU525929B2 (en) 1982-12-09
ATA65679A (en) 1981-01-15

Similar Documents

Publication Publication Date Title
GB2014043A (en) Injectable embolization and occlusion solutions
ATE187646T1 (en) USE OF ACTIVE INGREDIENTS CONTAINING COPPER TO ACCELERATE WOUND HEALING
SE8804661D0 (en) PERFUSATE FOR THE PRESERVATION OF ORGANS
DE69127888D1 (en) Preservation solution for cells
FI850835L (en) BIOLOGICAL SOFTERFALLANDE POLYPEPTIDES OCH DESS ANVAENDNING FOER EN STEGVIS SKEENDE FRIGOERING AV CEILINGS.
WO1987005300A3 (en) Protein preservation
ES8505546A1 (en) Method for stabilizing tumor necrosis factor and a stable aqueous solution or powder containing said factor.
JPS562962A (en) Glycolic acid oxidase inhibitor 44substitutedd33hydroxyy33pyrolinee2*55done
FR2523956B1 (en)
ATE72963T1 (en) CONDITIONING LIQUIDS OF TOOTH OR BONE SUBSTANCE.
BR9707888A (en) Preservation and / or freezing medium for biological material, composition and storage process for biological material
NO160932C (en) PROCEDURE AND BROWN OPERATING FLUID TO REDUCE THE CORRODING EFFECT FOR Aqueous SALT SOLUTION ON PERROMETAL SURFACES.
SE7612164L (en) PROCEDURE FOR THE PREPARATION OF COAGULATED EGG WHITE SUBSTANCE
ES2038733T3 (en) PROCEDURE FOR PREPARING AN INJECTABLE SOLUTION OF THIOCTIC ACID SALT WITH THROMETHANOL AND / OR BASIC AMINO ACIDS.
CH557138A (en) USE OF BIOLOGICAL PROTEASE INHIBITORS FOR THE PRESERVATION OF FOOD AND ORGANS AND TISSUE FOR TRANSPLANTATION.
NO882731L (en) PROCEDURE FOR STABILIZING LEUKOCYTES.
EP0188262A3 (en) Process for the isolation of chicken egg white cystatine, antiviral agents containing it and its use as viral protease inhibitor
NO158984C (en) APPLICATION OF (S) -BETA-FARNESEN IN LIQUID FORM OR OF A (E) -BETA-FARNESEN-CONTAINING LIQUID AS A CONTACT INSECTICIDE AGAINST ALEPHUS.
ATE124706T1 (en) METHOD FOR ISOLATION OF BASAL MEMBRANE PROTEINS FROM HUMAN AND ANIMAL TISSUES.
GB1110576A (en) Preservative for human and animal eyes
SE8800467L (en) HUDGENOMGAANG
KR920021038A (en) Ionized Animal Calcium Food Preservation
GR70665B (en)
SU611620A1 (en) Method of anesthesia at bone fractures
GB2019409A (en) High protein, solid dietary food product, hydrolysed gelatine

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Effective date: 19990128